+13.1%
GSK vs ZBH
+11.3%
+1.8%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ZBH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.0% | +13.5% | -8.5% | +1.6% |
| 7D | +4.9% | +14.3% | -9.3% | +1.3% |
| 30D | +9.9% | +20.3% | -10.4% | +4.7% |
| 3M | +0.2% | +15.3% | -15.1% | -3.6% |
| 6M | +2.3% | +33.9% | -31.6% | -4.8% |
| YTD | +7.1% | +23.5% | -16.4% | +0.4% |
| 1Y | +13.1% | +7.9% | +5.2% | +7.0% |
| All | +13.1% | +11.3% | +1.8% | +7.0% |
Cumulative growth
Daily Returns
Daily percentage return beside ZBH.
Daily Out/Under-Performance
Portfolio return minus ZBH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ZBH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ZBH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling